BlackRock Institutional Trust Company, N.A. - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 30 filers reported holding CASI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$259,000
+3.6%
225,6500.0%0.00%
Q3 2016$250,000
-5.3%
225,6500.0%0.00%
Q2 2016$264,000
+10.5%
225,6500.0%0.00%
Q1 2016$239,000
+10.1%
225,6500.0%0.00%
Q4 2015$217,000
-10.0%
225,6500.0%0.00%
Q3 2015$241,000
-40.3%
225,6500.0%0.00%
Q2 2015$404,000
+21.3%
225,6500.0%0.00%
Q1 2015$333,000
+11.7%
225,650
+0.7%
0.00%
Q4 2014$298,000
-25.7%
224,1440.0%0.00%
Q3 2014$401,000224,1440.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 896,137$4,185,0002.27%
Wellington Shields Capital Management, LLC 888,333$4,149,0000.67%
Manatuck Hill Partners, LLC 15,090$70,0000.03%
IHT Wealth Management, LLC 10,725$50,0000.01%
Perceptive Advisors 43,682$204,0000.01%
ALPS ADVISORS INC 153,234$716,0000.01%
ROYCE & ASSOCIATES LP 78,742$368,0000.00%
MEEDER ASSET MANAGEMENT INC 5,863$28,0000.00%
Tower Research Capital LLC (TRC) 5,974$28,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 18,585$86,7920.00%
View complete list of CASI PHARMACEUTICALS INC shareholders